Beijing Science Sun Pharmaceutical Co.,Ltd.’s Net Profit Rose 147.9% in First Quarter of 2022

Beijing Science Sun Pharmaceutical Co.,Ltd. (北京赛升药业股份有限公司) (300485.SZ) reported a net profit of 105.8 million yuan in the first quarter of 2022, up 147.9% year-on-year.

Meanwhile, the company posted 192.1 million yuan in revenue, down 17.6% year-on-year.

At the end of the reporting period, it had 3.5 billion yuan in total assets and 87.8 million yuan in total liabilities, with a liability-to-asset ratio of 2.5%.